0001526054-26-000004.txt : 20261119
0001526054-26-000004.hdr.sgml : 20261119
20261119163151
ACCESSION NUMBER: 0001526054-26-000004
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering
FILED AS OF DATE: 20261119
DATE AS OF CHANGE: 20261119
EFFECTIVENESS DATE: 20261119
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Mosaic Biosciences, Inc.
CENTRAL INDEX KEY: 0001526054
ORGANIZATION NAME:
EIN: 271127073
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-605439
FILM NUMBER: 261575405
BUSINESS ADDRESS:
STREET 1: 5710 FLATIRONS PARKWAY
CITY: BOULDER
STATE: CO
ZIP: 80301
BUSINESS PHONE: 720-362-0910
MAIL ADDRESS:
STREET 1: 5710 FLATIRONS PARKWAY
CITY: BOULDER
STATE: CO
ZIP: 80301
D
1
primary_doc.xml
X0708
D
LIVE
0001526054
Mosaic Biosciences, Inc.
5710 Flatirons Parkway
BOULDER
CO
COLORADO
80301
720-362-0910
DELAWARE
None
None
Corporation
true
Martin
Stanton
5710 Flatirons Parkway
Boulder
CO
COLORADO
80301
Director
Eric
Furfine
5710 Flatirons Parkway
Boulder
CO
COLORADO
80301
Executive Officer
Director
Dan
Mitchell
5710 Flatirons Parkway
Boulder
CO
COLORADO
80301
Director
Jeanette
W.
Welsh
5710 Flatirons Parkway
Boulder
CO
COLORADO
80301
Director
Rob
J.
Capone
5710 Flatirons Parkway
Boulder
CO
COLORADO
80301
Director
Jean-Pierre
Wery
5710 Flatirons Parkway
Boulder
CO
COLORADO
80301
Executive Officer
Director
Deval
Lashkari
5710 Flatirons Parkway
Boulder
CO
COLORADO
80301
Director
Dr. Lashkari was elected a director in connection with the closing of the Offering.
Brooke
Delgado
5710 Flatirons Parkway
Boulder
CO
COLORADO
80301
Executive Officer
Biotechnology
Decline to Disclose
- 06b
false
2026-10-14
false
true
false
0
3000000
3000000
0
false
3
0
0
0
Other than the payment of salaries and other compensation and benefits no officer, director or promoter will receive any payments from the proceeds of this offering.
false
Mosaic Biosciences, Inc.
/s/ Jean-Pierre Wery
Jean-Pierre Wery
Chief Executive Officer
2026-11-19